The Effect of Exercise on Cardiotoxicity in Women with Breast Cancer Receiving Anthracycline-based chemotherapy: A Systematic Review and Meta-analysis
CONCLUSIONS: Exercise was associated with an improvement in maximal oxygen uptake among women with breast cancer receiving anthracycline-based chemotherapy. .PMID:38104536 | DOI:10.1159/000535737 (Source: Oncology)
Source: Oncology - December 17, 2023 Category: Cancer & Oncology Authors: Cho-Han Chiang Yu-Cheng Chang Yulin Haw Jia Yi Tan Cho-Hsien Chiang Yuan Ping Hsia Cho-Hung Chiang Source Type: research
Diversity in Renal Mass Data Cohorts: Implications for Urology AI Researchers
Conclusion Heterogeneities between cohorts need to be considered in future AI training and cross-validation for renal masses.PMID:38104555 | DOI:10.1159/000535841 (Source: Oncology)
Source: Oncology - December 17, 2023 Category: Cancer & Oncology Authors: Harmony Selena Cen Siddhartha Dandamudi Xiaomeng Lei Chris Weight Mihir Desai Inderbir Gill Vinay Duddalwar Source Type: research
The Effect of Exercise on Cardiotoxicity in Women with Breast Cancer Receiving Anthracycline-based chemotherapy: A Systematic Review and Meta-analysis
CONCLUSIONS: Exercise was associated with an improvement in maximal oxygen uptake among women with breast cancer receiving anthracycline-based chemotherapy. .PMID:38104536 | DOI:10.1159/000535737 (Source: Oncology)
Source: Oncology - December 17, 2023 Category: Cancer & Oncology Authors: Cho-Han Chiang Yu-Cheng Chang Yulin Haw Jia Yi Tan Cho-Hsien Chiang Yuan Ping Hsia Cho-Hung Chiang Source Type: research
Diversity in Renal Mass Data Cohorts: Implications for Urology AI Researchers
Conclusion Heterogeneities between cohorts need to be considered in future AI training and cross-validation for renal masses.PMID:38104555 | DOI:10.1159/000535841 (Source: Oncology)
Source: Oncology - December 17, 2023 Category: Cancer & Oncology Authors: Harmony Selena Cen Siddhartha Dandamudi Xiaomeng Lei Chris Weight Mihir Desai Inderbir Gill Vinay Duddalwar Source Type: research
Significance of Ultra-Radical Surgery in Extensive Metastatic Ovarian Growing Teratoma Syndrome
CONCLUSION: The survival outcomes in extensive metastatic ovarian GTS were satisfactory after ultra-radical surgery, while a proper therapeutic plan should be established due to the high perioperative risks.PMID:38096801 | DOI:10.1159/000533411 (Source: Oncology)
Source: Oncology - December 14, 2023 Category: Cancer & Oncology Authors: Sijian Li Tao Wang Huayang Du Hui Tang Tianyu Zhang Rundong Zhang Xinyue Zhang Jiaxin Yang Source Type: research
Significance of Ultra-Radical Surgery in Extensive Metastatic Ovarian Growing Teratoma Syndrome
CONCLUSION: The survival outcomes in extensive metastatic ovarian GTS were satisfactory after ultra-radical surgery, while a proper therapeutic plan should be established due to the high perioperative risks.PMID:38096801 | DOI:10.1159/000533411 (Source: Oncology)
Source: Oncology - December 14, 2023 Category: Cancer & Oncology Authors: Sijian Li Tao Wang Huayang Du Hui Tang Tianyu Zhang Rundong Zhang Xinyue Zhang Jiaxin Yang Source Type: research
Significance of Ultra-Radical Surgery in Extensive Metastatic Ovarian Growing Teratoma Syndrome
CONCLUSION: The survival outcomes in extensive metastatic ovarian GTS were satisfactory after ultra-radical surgery, while a proper therapeutic plan should be established due to the high perioperative risks.PMID:38096801 | DOI:10.1159/000533411 (Source: Oncology)
Source: Oncology - December 14, 2023 Category: Cancer & Oncology Authors: Sijian Li Tao Wang Huayang Du Hui Tang Tianyu Zhang Rundong Zhang Xinyue Zhang Jiaxin Yang Source Type: research
The rate of clinically significant prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation: A systematic review and meta-analysis
CONCLUSION: Repeat biopsy can be safely deferred for patients diagnosed with ASAP. We believe our results may help to improve management strategies and encourage clinicians to choose more patient-friendly or non-invasive diagnostic evaluations.PMID:38061334 | DOI:10.1159/000535123 (Source: Oncology)
Source: Oncology - December 7, 2023 Category: Cancer & Oncology Authors: Wen-Tong Ji Xue-Fei Jin Yao Wang Source Type: research
RNA Expression-based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab
Conclusion Xerna™ TME Panel analysis in patients with refractory metastatic pMMR CRC who were treated with regorafenib plus nivolumab might be of value for predictive clinical benefit. Further studies are needed to evaluate the predictive role of Xerna™ TME Panel analysis in patients with refractory metastatic pMMR CRC.PMID:38061339 | DOI:10.1159/000535599 (Source: Oncology)
Source: Oncology - December 7, 2023 Category: Cancer & Oncology Authors: Ruoyu Miao Dae Won Kim James Yu Mokenge Malafa Rutika Mehta Jonathan Strosberg Iman Imanirad Seema Iyer Mark Uhlik Laura Benjamin Richard Kim Source Type: research
The rate of clinically significant prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation: A systematic review and meta-analysis
CONCLUSION: Repeat biopsy can be safely deferred for patients diagnosed with ASAP. We believe our results may help to improve management strategies and encourage clinicians to choose more patient-friendly or non-invasive diagnostic evaluations.PMID:38061334 | DOI:10.1159/000535123 (Source: Oncology)
Source: Oncology - December 7, 2023 Category: Cancer & Oncology Authors: Wen-Tong Ji Xue-Fei Jin Yao Wang Source Type: research
RNA Expression-based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab
Conclusion Xerna™ TME Panel analysis in patients with refractory metastatic pMMR CRC who were treated with regorafenib plus nivolumab might be of value for predictive clinical benefit. Further studies are needed to evaluate the predictive role of Xerna™ TME Panel analysis in patients with refractory metastatic pMMR CRC.PMID:38061339 | DOI:10.1159/000535599 (Source: Oncology)
Source: Oncology - December 7, 2023 Category: Cancer & Oncology Authors: Ruoyu Miao Dae Won Kim James Yu Mokenge Malafa Rutika Mehta Jonathan Strosberg Iman Imanirad Seema Iyer Mark Uhlik Laura Benjamin Richard Kim Source Type: research
The rate of clinically significant prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation: A systematic review and meta-analysis
CONCLUSION: Repeat biopsy can be safely deferred for patients diagnosed with ASAP. We believe our results may help to improve management strategies and encourage clinicians to choose more patient-friendly or non-invasive diagnostic evaluations.PMID:38061334 | DOI:10.1159/000535123 (Source: Oncology)
Source: Oncology - December 7, 2023 Category: Cancer & Oncology Authors: Wen-Tong Ji Xue-Fei Jin Yao Wang Source Type: research
RNA Expression-based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab
Conclusion Xerna™ TME Panel analysis in patients with refractory metastatic pMMR CRC who were treated with regorafenib plus nivolumab might be of value for predictive clinical benefit. Further studies are needed to evaluate the predictive role of Xerna™ TME Panel analysis in patients with refractory metastatic pMMR CRC.PMID:38061339 | DOI:10.1159/000535599 (Source: Oncology)
Source: Oncology - December 7, 2023 Category: Cancer & Oncology Authors: Ruoyu Miao Dae Won Kim James Yu Mokenge Malafa Rutika Mehta Jonathan Strosberg Iman Imanirad Seema Iyer Mark Uhlik Laura Benjamin Richard Kim Source Type: research
The rate of clinically significant prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation: A systematic review and meta-analysis
CONCLUSION: Repeat biopsy can be safely deferred for patients diagnosed with ASAP. We believe our results may help to improve management strategies and encourage clinicians to choose more patient-friendly or non-invasive diagnostic evaluations.PMID:38061334 | DOI:10.1159/000535123 (Source: Oncology)
Source: Oncology - December 7, 2023 Category: Cancer & Oncology Authors: Wen-Tong Ji Xue-Fei Jin Yao Wang Source Type: research
RNA Expression-based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab
Conclusion Xerna™ TME Panel analysis in patients with refractory metastatic pMMR CRC who were treated with regorafenib plus nivolumab might be of value for predictive clinical benefit. Further studies are needed to evaluate the predictive role of Xerna™ TME Panel analysis in patients with refractory metastatic pMMR CRC.PMID:38061339 | DOI:10.1159/000535599 (Source: Oncology)
Source: Oncology - December 7, 2023 Category: Cancer & Oncology Authors: Ruoyu Miao Dae Won Kim James Yu Mokenge Malafa Rutika Mehta Jonathan Strosberg Iman Imanirad Seema Iyer Mark Uhlik Laura Benjamin Richard Kim Source Type: research
